16th Annual North Carolina Research Triangle Pulmonary Hypertension Symposium

Date: Friday, November 1, 2024

Time: 8:00 a.m. - 3:15 p.m.

Location: Durham Convention Center, 301 W. Morgan Street, Durham, NC 27701 (map)

Joint Accreditation Statement

This activity has been planned and implemented by the Duke University Health System Department of Clinical Education & Professional Development for the advancement of patient care. In support of improving patient care, the Duke University Health System Department of Clinical Education & Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team.

Category 1: Duke University Health System Department of Clinical Education and Professional Development designates this activity for a maximum of 6 AMA PRA Category 1 Credit(s)TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Nurse CE: Duke University Health System Department of Clinical Education and Professional Development designates this activity for up to 6 credit hours for nurses. Nurses should claim only credit commensurate with the extent of their participation in this activity.

Pharmacists: Duke University Health System Department of Clinical Education and Professional Development designates this activity for a maximum of 6 ACPE credit hours. Universal Activity Numbers: A0000655-0000-24-210-L04-P, JA0000655-0000-24-210-L04-T

Duke Health Clinical Education and Professional Development is accredited by the International Association for Continuing Education and Training (IACET), and is authorized to issue IACET CEU, and authorized by IACET to offer 0.6 CEUs for this program.

Course Overview

The overall goal of the 16^th Annual North Carolina Research Triangle Pulmonary Hypertension Symposium is to provide education for physicians and other allied health professionals involved in diagnosing and treating Pulmonary Arterial Hypertension (PAH), keeping them abreast of the ever-changing diagnostic and treatment paradigms, as well as timing of referral for more advanced care to pulmonary hypertension centers for healthcare providers at the front lines of screening for and diagnosing PAH. It will also address consideration of advanced mechanical circulatory support and/or lung transplant when therapies are inadequate. Our local and invited keynote faculty will incorporate several case-based discussions during the symposium.

DOWNLOAD AGENDA

Co-Course Directors

H. James Ford, MD

Professor of Medicine
Director, Pulmonary Hypertension Program
Co-Medical Director, UNC Pulmonary Clinics
Division of Pulmonary Diseases and Critical Care Medicine
University of North Carolina at Chapel Hill

(View Bio)

Terry Fortin, MD, MS

Associate Professor of Medicine
Co-Director, Duke Pulmonary Vascular Disease Center
Division of Cardiology
Duke University Medical Center

(View Bio)

Invited Speakers

William Auger, MD
Adjunct Professor, Department of Medicine
Duke University

Hilary DuBrock, MD
Associate Professor of Medicine
Critical Care Specialist, Internist, & Pulmonologist
Mayo Clinic

David Ishizawar, MD
Associate Professor of Medicine
Division of Cardiology
University of North Carolina at Chapel Hill

Arvind Konkimalla, MD
House Staff, Department of Medicine
Duke University

Richard Krasuski, MD
Professor of Medicine
Division of Cardiology
Duke University

Barbara LeVarge, MD
Assistant Professor of Medicine
Associate Director, Pulmonary Hypertension Program
Division of Pulmonary Diseases and Critical Care Medicine
University of North Carolina at Chapel Hill

Bradley Maron, MD
Director, Pulmonary Hypertension Program
University of Maryland

Maura Thornton, MD
Fellow
University of North Carolina at Chapel Hill

Sudarshan Rajagopal, MD, PhD
Associate Professor of Medicine
Co-Director, Duke Pulmonary Vascular Disease Center
Division of Cardiology
Duke University

Jason Weatherald, MD
Associate Professor, Faculty of Medicine & Dentistry – Medicine Dept.
University of Alberta

Jordan Whitson, MD
Assistant Professor of Medicine
Division of Pulmonary, Allergy and Critical Care Medicine
Duke University

Target Audience

This program is designed to meet the continuing education (CE) needs of pulmonologists, cardiologists, nurses, pharmacists, and other allied healthcare professionals involved in the treatment of pulmonary hypertension.

Learning Objectives

Describe the diagnosis and clinical classification of Pulmonary Hypertension, according to the 7th World Symposium and recent 2022 ERS/ESC guideline updates, as well as the treatment options with respect to PAH-specific therapies.

Recognize how PH patient characteristics and phenotypes may change over the patient’s lifespan as patients with PAH are living longer and may develop cardiovascular and other comorbidities associated with older age.

Early detection and screening are key in improving PAH disease course, outcomes and mortality. Recognize current and emerging tools, as well as gaps and opportunities to enhance the screening, detection and ultimate diagnosis of PAH.

Learn about patient reported outcome tools that exist to assess health related quality of life in PH, and how these might be applied in research and routine clinical care. Also recognize how they may further the goal of providing patient-centered care shared decision-making.

Right heart catheterization is the gold standard for PH diagnosis. Learn about best practices for the procedure, as well as emerging research on additional metrics to inform patient diagnosis and prognosis.

Recognize how social determinants of health intersecting with other patient factors such as race, ethnicity, and socioeconomic status may shape outcomes in patients with PH.

Through a series of cased based presentations, gain a deeper understanding and recognition of nuanced clinical situations in which the role and management of PAH therapy can be challenging to determine and navigate. Learn approaches to manage these patient scenarios from PH center expert clinicians.

Learn about the past and current approaches to PAH clinical trial design to enable the investigation and potential approval of new candidate PAH therapies. Discuss what may be needed for trials to evolve as the treatment landscape for PAH changes in the future.

Registration Fees

Industry representatives: $250
Physicians: $200
Non-physicians (NPs, PAs, nurses, pharmacists, allied health professionals, etc.): $60
Enduring credit: Complimentary, but registration is required

Accomodations & Room Rates

A block of hotel rooms has been reserved at the Durham Marriott City Center, 201 Foster Street, Durham, NC 27701 for 10/31/24 and 11/1/24. Rooms are $229.00 per night plus applicable taxes. The room block will be held until Wednesday, October 2, 2024, but may sell out prior to this date. To reserve your room at the conference rate, please call 919-768-6000 and identify yourself as part of the NC Research Triangle Pulmonary Hypertension Symposium; to make an online reservation, click here.

Cancellation Policy

All cancellation requests must be submitted in writing to Christy Darnell via email (christy.darnell@duke.edu). There will be no refunds if cancellations are made after October 1, 2024.

Claiming CE Credit After the Symposium

To complete all course requirements and claim continuing education credit(s), please do the following:

Receive email from Duke CME office next week with link to the course evaluation.
Complete the course evaluation.
Attest to your hours of completion.
Download your certificate.